Regulation 2023/1182 - Specific rules relating to medicinal products for human use intended to be placed on the market in Northern Ireland

Please note

This page contains a limited version of this dossier in the EU Monitor.

Contents

  1. Current status
  2. Key information
  3. Key dates
  4. Original proposal
  5. Sources and disclaimer
  6. Full version
  7. EU Monitor

1.

Current status

This regulation has been published on June 20, 2023 and entered into force on June 21, 2023.

2.

Key information

official title

Regulation (EU) 2023/1182 of the European Parliament and of the Council of 14 June 2023 on specific rules relating to medicinal products for human use intended to be placed on the market in Northern Ireland and amending Directive 2001/83/EC
 
Legal instrument Regulation
Number legal act Regulation 2023/1182
Original proposal COM(2023)122 EN
CELEX number i 32023R1182

3.

Key dates

Document 14-06-2023; Date of signature
Publication in Official Journal 20-06-2023; OJ L 157 p. 1-7
Signature 14-06-2023
Effect 01-01-1001; Application See Art 14
21-06-2023; Entry into force Date pub. +1 See Art 14
End of validity 31-12-9999

4.

Original proposal

 

5.

Sources and disclaimer

For further information you may want to consult the following sources that have been used to compile this dossier:

This dossier is compiled each night drawing from aforementioned sources through automated processes. We have invested a great deal in optimising the programming underlying these processes. However, we cannot guarantee the sources we draw our information from nor the resulting dossier are without fault.

 

6.

Full version

This page is also available in a full version containing the legal context, de Europese rechtsgrond, other dossiers related to the dossier at hand and the related cases of the European Court of Justice.

The full version is available for registered users of the EU Monitor by ANP and PDC Informatie Architectuur.

7.

EU Monitor

The EU Monitor enables its users to keep track of the European process of lawmaking, focusing on the relevant dossiers. It automatically signals developments in your chosen topics of interest. Apologies to unregistered users, we can no longer add new users.This service will discontinue in the near future.